From Name

From Email

To Name

To Email

Message

Study: 5-year review of all Alzheimer's drugs in development shows reason for optimism

from University of Nevada, Las Vegas via EurekAlert!

Study: 5-year review of all Alzheimer's drugs in development shows reason for optimism University of Nevada, Las Vegas via EurekAlert! Dr. Jeffrey L. Cummings, UNLV research professor and a leading expert on Alzheimer's disease clinical trials, led a five-year review of all Alzheimer's drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer's. The paper, "Alzheimer's disease drug development pipeline: 2020," was published in the journal Alzheimer's & Dementia: Translational Research & Clinical Interventions. READ MORE

more